
Breast Filler Korea Honest Safety Information at RE:BERRY Hongdae
Understand the real safety picture before any decision — breast filler korea carries serious regulatory and screening concerns, including the 2016 prohibition of copolyamide breast fillers in Korea, so RE:BERRY Hongdae offers honest English information from ₩19,000 (about $14) with Dr. Jae-Hong Kim and directs you to a qualified plastic surgery specialist, directly connected to Hongik University Station via AREX. See how our information consultation works and the published evidence below.
Visit RE:BERRY across Seoul, Korea
Hongdae opens soon. Until then, explore our flagships — tap a clinic to view it.
ONE RE:BERRY BRAND · MFDS-REGISTERED DEVICES · MULTILINGUAL CARE AT EVERY LOCATION
Breast Filler Korea — Honest Safety Information in 2026
Breast filler korea raises serious safety and regulatory concerns: copolyamide breast fillers were prohibited in Korea in 2016 and no filler is FDA-approved for breast augmentation. RE:BERRY Hongdae gives honest information from ₩19,000 (about $14) and refers you to a qualified plastic surgery specialist, directly connected to Hongik University Station via AREX.
Breast filler korea refers to injecting a soft-tissue material into the breast to add volume without implants or surgery. This is very different from routine facial filler, because the breast requires far larger volumes, which raises the risk profile substantially. This page is informational and educational: RE:BERRY Hongdae does not assert that any specific breast-augmentation injection is offered here, and any decision should be made only with a qualified, licensed specialist. Historically, copolyamide gels marketed as Aquafilling were used for this purpose; their major component is chemically comparable to polyacrylamide gel, and their use for breast augmentation was prohibited in Korea by the Korean Academic Society of Aesthetic and Reconstructive Breast Surgery in 2016 after reports of masses, deformity, infection, gel migration, asymmetry, and loss of the ability to breastfeed. Hyaluronic-acid breast injection has also been associated with serious complications including infection and tissue necrosis. There is no FDA-approved filler for breast augmentation in the United States. In South Korea, soft-tissue injection fillers are regulated by the MFDS as higher-class medical devices requiring pre-market review, and any product’s specific approval and permitted indication should be verified directly with the MFDS and the clinic. A further honest concern is screening: injected material can obscure a mammogram and complicate breast-cancer detection, which is rarely mentioned in marketing. Complications may appear early, often technique-related such as infection or vascular occlusion, or with delay of weeks, months, or years, often material-related such as nodules, migration, or deformity. At RE:BERRY Hongdae in Mapo-gu’s Hongdae district, Seoul’s youth-culture and design hub, the honest first step is an English information consultation and a referral to a board-eligible plastic surgery specialist, rather than assuming any injection is suitable. The clinic sits directly above Hongik University Station, which connects to the AREX airport express, so travelers ride from Incheon Airport T1 or T2 to our door with no line transfer. Dr. Jae-Hong Kim runs 60-90 minute English consultations, far longer than Korea’s 4.3-minute national average, with 8-language support and WhatsApp aftercare, focused on informed, evidence-based decision-making rather than a sales pitch.
Breast Filler Korea Information Consultation Pricing at RE:BERRY
Breast Filler Korea — Why RE:BERRY Hongdae Shows No Result Photos
How RE:BERRY Hongdae Handles a Breast Filler Korea Information Request

Step 1: 60-90 Minute Honest Information Consultation
Dr. Jae-Hong Kim reviews the real evidence on breast filler korea in a 60-90 minute English consultation, far above Korea’s 4.3-minute average, explaining the 2016 copolyamide prohibition, the lack of any FDA-approved breast filler, and the serious complication profile before any decision is considered.

Step 2: Reviewing Screening and Complication Risks
Dr. Kim explains 2 categories of risk honestly: early technique-related events such as infection or vascular occlusion, and delayed material-related events such as nodules, migration, or deformity over months to years, plus how injected material can obscure a mammogram and delay cancer detection.

Step 3: Verifying Licenses and MFDS Device Status
Dr. Kim shows you how to independently verify a Korean clinic and physician license and confirm a device’s MFDS approval status. He walks through 4 checks so you can confirm any provider and product yourself rather than relying on marketing claims.

Step 4: Referral to a Qualified Plastic Surgery Specialist
Rather than assume suitability, RE:BERRY Hongdae directs you to a qualified, board-eligible plastic surgery specialist to weigh evidence-based options in 1 focused referral. When ready, board the AREX at Hongik University Station below for the 60-minute ride to Incheon Airport, with 8-language WhatsApp support.
Breast Filler Korea — Honest Information and Complication Timeline
- Transparent ₩19,000 (about $14) Information Consultation RE:BERRY Hongdae publishes its English information consultation fee online from ₩19,000 (about $14), itemized before you book, with no pressure to proceed. The 60-90 minute honest review of breast filler korea evidence is quoted transparently from ₩19,000 (about $14) so you know the cost first.
- Regulatory Honesty First RE:BERRY Hongdae states plainly that copolyamide breast fillers were prohibited for breast augmentation in Korea in 2016 and that no filler is FDA-approved for breast augmentation. This regulatory context is put before any decision, not hidden behind a sales pitch.
- Screening-Safety Awareness Dr. Jae-Hong Kim explains how injected breast material can obscure a mammogram and delay breast-cancer detection, a serious concern rarely mentioned in marketing. Understanding this screening risk is central to an informed decision.
- Independent Verification Skills RE:BERRY Hongdae teaches you to verify a clinic license, physician license, and MFDS device approval yourself across 4 checks. This consumer-protection framing helps you evaluate any provider objectively.
- Referral to a Qualified Specialist Rather than assuming any injection is suitable, Dr. Jae-Hong Kim refers you to a qualified, board-eligible plastic surgery specialist. Open 365 days in 8 languages, directly connected to Hongik University Station via AREX with 0 line transfers from Incheon Airport.
| Timeline | What to Expect |
|---|---|
| Consultation | A 60-90 minute honest information session reviews the evidence, regulation, and complication profile before any decision. |
| Early (days-weeks) | If a breast injection were performed elsewhere, early technique-related events such as infection or vascular occlusion can appear within days to weeks. |
| Delayed (months-years) | Material-related events such as nodules, migration, asymmetry, or deformity can emerge over months to years, per published reports. |
| Screening impact | Injected material can obscure a mammogram indefinitely, complicating breast-cancer detection at any future screening. |
| Referral | RE:BERRY Hongdae directs you to a qualified plastic surgery specialist to weigh evidence-based options with 1 focused referral. |
| Ongoing | Any information follow-up is quoted transparently from ₩19,000 (about $14), with no obligation to proceed with any procedure. |
Breast Filler Korea vs Regulated Options — A Safety Comparison
| Factor | Prohibited/Unapproved Breast Filler | Regulated Specialist Path | Source |
|---|---|---|---|
| Regulatory status | Copolyamide prohibited in Korea (2016) | MFDS-regulated, specialist-guided care | Roh 2016 |
| FDA approval | No FDA-approved breast filler | Approved options assessed by a specialist | Trignano 2020 |
| Complication profile | Nodules, migration, infection, necrosis | Managed within a monitored specialist setting | Kim 2021 |
| Screening impact | Can obscure a mammogram | Screening clarity preserved | Peer-reviewed literature |
| Reversibility | Often difficult or not reversible | Specialist plans reversible or removable options | Trignano 2020 |
| Verification | Marketing claims, hard to confirm | Verifiable clinic, physician, and device licenses | RE:BERRY records |
| Honest guidance | Rarely disclosed risks | Evidence-based counseling first | Kim 2021 |
Why This Matters
The core of breast filler korea safety is regulatory honesty: copolyamide breast fillers were prohibited in Korea in 2016 and no breast filler is FDA-approved. RE:BERRY Hongdae states this plainly and refers you to a qualified plastic surgery specialist rather than promoting any injection.
Doctor continuity affects honest counseling. According to KHIDI’s 2025 Medical Tourism Survey, 41.4% of patients ranked ‘same doctor throughout treatment’ as their number 1 priority when choosing a Korean clinic. The assigned RE:BERRY Hongdae physician gives your information consultation personally.
Korea’s average outpatient consultation is 4.3 minutes, the shortest in the OECD (16.4-minute average). RE:BERRY’s 60-90 minute consultations are far longer, so regulation, complications, and screening risk are explained carefully rather than rushed.
Your Information Consultation Physician at RE:BERRY Hongdae
Dr. Jae-Hong Kim
- Aesthetic Medicine Specialist, RE:BERRY Clinic Hongdae
- Korean Ministry of Health and Welfare Medical License No.138911
- Regular Member, Korean Dermatological Association (kda.or.kr)
- Honest patient-education and clinic-verification counseling
- Referral coordination to qualified plastic surgery specialists
Medically reviewed by Dr. Jae-Hong Kim, Aesthetic Medicine Specialist, RE:BERRY
SCIENTIFIC EVIDENCE Behind Breast Filler Korea Safety
Why Copolyamide Breast Filler Was Prohibited in Korea
The prohibition of copolyamide breast filler is documented in the peer-reviewed record. Roh TS (2016), in a position statement of the Korean Academic Society of Aesthetic and Reconstructive Breast Surgery published in Archives of Aesthetic Plastic Surgery, set out the society’s position against Aquafilling for breast augmentation after reports of masses, deformity, infection, gel migration, and asymmetry. Its major component is chemically comparable to polyacrylamide gel, and this 2016 statement is the regulatory basis RE:BERRY Hongdae cites for breast filler korea when explaining why the material was prohibited.
Documented Complications of Breast Injection
Complication reports span both copolyamide and hyaluronic-acid breast injection. Kim H, Cho SH, Lee SJ et al. (2021) in Plastic and Reconstructive Surgery Global Open examined the safety of copolyamide filler injection for breast augmentation and documented adverse outcomes, while Trignano E, Baccari M, Pili N et al. (2020) in Gland Surgery reported complications after breast augmentation with hyaluronic acid, including infection and tissue necrosis. Across these 2 published sources, RE:BERRY Hongdae shows patients that serious events are reported for both material types rather than a single outlier product.
Complication timing matters for informed consent. Early events, often technique-related, such as infection or vascular occlusion, tend to appear within days to weeks, whereas material-related events, such as nodules, migration, asymmetry, or deformity, can emerge over months to years. RE:BERRY Hongdae uses these 2 timelines from the literature so patients understand that an initially uneventful result does not rule out later problems from breast filler korea.
Screening safety is a distinct and serious evidence-based concern that is rarely disclosed in marketing. Injected breast material can obscure mammographic interpretation and complicate breast-cancer detection, which is 1 major reason plastic surgery societies caution against large-volume breast fillers. Regulatory context reinforces this: there is no FDA-approved filler for breast augmentation, and in Korea the MFDS regulates soft-tissue injection fillers as higher-class devices requiring pre-market review, so any product’s approval and indication must be verified directly.
Roh TS. Letter: position statement of Korean Academic Society of Aesthetic and Reconstructive Breast Surgery concerning the use of Aquafilling for breast augmentation. Arch Aesthetic Plast Surg. 2016;22(1):45-46. doi:10.14730/aaps.2016.22.1.45
Kim H, Cho SH, Lee SJ, et al. Safety of copolyamide filler injection for breast augmentation. Plast Reconstr Surg Glob Open. 2021;9(2):e3296. doi:10.1097/GOX.0000000000003296
Trignano E, Baccari M, Pili N, et al. Complications after breast augmentation with hyaluronic acid: a case report. Gland Surg. 2020;9(6):2193-2198. doi:10.21037/gs-20-448
Unukovych D, Khrapach V, Wickman M, et al. Polyacrylamide gel injections for breast augmentation: management of complications. J Plast Reconstr Aesthet Surg. 2012;65(6):703-709. doi:10.1016/j.bjps.2011.11.047
Ono S, Ogawa R, Hyakusoku H. Complications after polyacrylamide hydrogel injection for soft-tissue augmentation. Plast Reconstr Surg. 2010;126(4):1349-1357. doi:10.1097/PRS.0b013e3181ead122
Cheong JY, Kim SH, Park ES, et al. Aquafilling-related breast complications in Korean patients: a clinical review. Ann Dermatol (Seoul). 2020;32(5):361-368. doi:10.5021/ad.2020.32.5.361
Only Authentic, Brand-Certified Equipment
Every device at RE:BERRY is MFDS-certified and manufacturer-verified. We never use counterfeit or grey-market equipment.
Numbers That Tell Our Story
Real procedures performed.
Frequently Asked Questions About Breast Filler Korea Safety
Regulatory prohibition, FDA status, complication profile, mammogram-screening risk, license verification, warning signs, and honest specialist referral from the RE:BERRY Hongdae team — with direct airport access via AREX.
Who gives the breast filler information consultation in Hongdae Seoul?
RE:BERRY Hongdae assigns 1 doctor, Dr. Jae-Hong Kim (Korean MOHW License No.138911), to give your honest breast filler korea information consultation personally. In a 60-90 minute English session he reviews the evidence and refers you to a qualified plastic surgery specialist, with no sales pressure.
Does the same doctor handle my breast filler information in Hongdae?
RE:BERRY Hongdae keeps 1 assigned doctor, Dr. Jae-Hong Kim, across your information consultation and referral. KHIDI 2025 data shows 41.4% of international patients rank same-doctor continuity as their number 1 priority, so he holds continuity to any related filler information and follow-up.
Is breast filler legal and approved in South Korea?
RE:BERRY Hongdae explains 1 key fact: copolyamide (Aquafilling-type) breast fillers were prohibited for breast augmentation in Korea by the relevant surgical society in 2016. Soft-tissue fillers are MFDS-regulated as higher-class devices, and any product’s approval and permitted indication must be verified directly with the MFDS and the clinic.
How much does the breast filler information consultation cost in 2026?
RE:BERRY Hongdae publishes 1 transparent quote for the English information consultation in the pricing section, itemized before you book. Korean clinics handle far higher aesthetic patient volume than most Western markets, so you gain an experienced, evidence-based 60-90 minute review and a specialist referral, with no obligation to proceed.
Are breast fillers banned in Korea and which materials were prohibited?
RE:BERRY Hongdae confirms 1 specific prohibition: copolyamide (Aquafilling-type) breast fillers were prohibited for breast augmentation in Korea in 2016 after reports of masses, migration, and infection. Korean surgical societies review more aesthetic cases than most markets.
| Material | Breast augmentation status |
|---|---|
| Copolyamide (Aquafilling) | Prohibited in Korea (2016) |
| Hyaluronic acid | Serious complications reported |
Is breast filler approved by the FDA in the United States?
RE:BERRY Hongdae states 1 clear fact: there is no FDA-approved filler for breast augmentation in the United States. Korean clinics assess more aesthetic patients than most markets, so Dr. Kim explains this honestly and refers you to a qualified specialist rather than presenting breast filler as an approved option.
Can breast filler interfere with a mammogram or cancer screening?
RE:BERRY Hongdae flags 1 serious risk: injected breast material can obscure a mammogram and complicate breast-cancer detection. This screening concern is rarely mentioned in marketing, so Dr. Kim raises it directly, because delayed cancer detection is a genuine safety consequence to weigh before any decision.
What are the risks and complications of a breast filler injection?
RE:BERRY Hongdae reviews 2 risk categories honestly: early technique-related events such as infection or vascular occlusion, and delayed material-related events such as nodules, migration, or deformity over months to years. Korean surgical societies document more of these cases than most markets.
| Timing | Typical events |
|---|---|
| Early | Infection, vascular occlusion |
| Delayed | Nodules, migration, deformity |
Why do plastic surgery societies caution against breast fillers?
RE:BERRY Hongdae cites 1 main reason: large-volume breast fillers carry serious complication and screening risks, which is why surgical societies caution against them. Korean societies review higher aesthetic case volume than most markets, so their 2016 position against copolyamide breast filler reflects extensive real-world outcome data, not caution alone.
How do I check that a clinic and doctor in Korea are properly licensed?
RE:BERRY Hongdae teaches 4 verification checks: confirm the clinic license, the physician license, the specialist qualification, and the MFDS device approval. Korean regulators track more aesthetic providers than most markets, so Dr. Kim shows you how to confirm any provider yourself and can point to further information.
What are the warning signs of a complication after a breast injection?
RE:BERRY Hongdae lists warning signs across 2 phases: early fever, spreading redness, severe pain, or skin colour change suggesting infection or vascular occlusion, and later new lumps, asymmetry, or shape change suggesting migration. If any appear, Dr. Kim advises urgent review by a qualified specialist without delay and points to further safety information.
Is hyaluronic acid breast filler a safe alternative to other fillers?
RE:BERRY Hongdae explains 1 caution: hyaluronic-acid breast injection has also been associated with serious complications, including infection and tissue necrosis, so it is not simply a safe substitute. Korean clinics review more filler cases than most markets, and Dr. Kim frames breast use as high-risk regardless of material type and can explain where HA filler is regulated.
What safer options should I discuss with a qualified specialist?
RE:BERRY Hongdae recommends 1 honest first step: an in-person consultation with a qualified, board-eligible plastic surgery specialist to weigh evidence-based, regulated options. Korean specialists handle higher aesthetic case volume than most markets, so Dr. Kim refers you rather than assuming any breast injection is suitable, and can share regulated filler information.
Can I get honest English breast procedure information as a tourist?
RE:BERRY Hongdae patients can complete a 60-90 minute English information consultation in 1 visit and fly home whenever they wish, since no procedure is performed here. Hongik University Station below the clinic connects to AREX, a 60-minute ride to Incheon Airport, fitting a short Seoul trip.
Why choose RE:BERRY Hongdae for honest breast filler information?
RE:BERRY Hongdae offers a 60-90 minute evidence-based review of breast filler korea, honest regulatory and screening context, license and MFDS verification guidance, and a referral to a qualified plastic surgery specialist from Dr. Jae-Hong Kim. Open 365 days in 8 languages via AREX. This information is educational and not medical advice; last reviewed by a licensed physician.
Book an Honest Breast Filler Information Consultation at RE:BERRY Hongdae
Get honest, evidence-based information about breast filler korea from ₩19,000 (about $14) with Dr. Jae-Hong Kim — including the 2016 Korea prohibition of copolyamide breast fillers, the absence of any FDA-approved breast filler, and the mammogram-screening risk — then a referral to a qualified plastic surgery specialist. No procedure is performed here; directly connected to Hongik University Station via AREX, open 365 days.
Related Treatments
Why Tens of Thousands of Foreign Patients Are Choosing This Seoul Skin Clinic — Business Wire, 2026-04-13
Book Your Personalized Consultation
Share your details and our multilingual team will contact you within 24 hours through your preferred messenger.
- ✓ Free online skin consultation with a doctor
- ✓ Personalized treatment plan & pricing
- ✓ Airport pickup coordination available
- ✓ 8-language support (EN/JP/CN/TW/TH/ES/MN/AR)
- ✓ Response within 24 hours via your preferred messenger
How to Find RE:BERRY Hongdae
Directly connected to Hongik University Station (Line 2, AREX, Gyeongui–Jungang Line) via the AREX underground passage. 3F & B2, 140 Yanghwa-ro, Mapo-gu, Seoul.
RE:BERRY Clinic Hongdae Opening Soon
3F & B2, 140 Yanghwa-ro, Mapo-gu, Seoul 04039
서울시 마포구 양화로 140, 3층·지하2층 (동교동 162-15)
Open now at: Gangnam · Myeongdong · Incheon Airport



